Pharmacovigilance Harmonization: A Global Priority
International Journal of Drug Delivery Technology · 25.04.2026 · 16 (22s)
DOI: 10.25258/ijddt.16.22s.14 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 25.04.2026. Verfasst von Manisha Manisha und 5 weiteren Autor:innen.
Abstract (Originalsprache)
In today’s interconnected world, where medicines frequently move across international borders, maintaining their safety has become a shared responsibility worldwide. Pharmacovigilance, which involves the detection, evaluation, understanding and prevention of harmful effects from medicines, is essential for public health protection. However, this field faces many challenges because regulatory systems are often fragmented, reporting requirements differ and resources and expertise vary across regions. These differences can create gaps in monitoring drug safety, leading to delays in spotting safety concerns and taking prompt action to safeguard patients. This article examines why harmonizing pharmacovigilance practices is no longer optional but an urgent global priority. It explores the wide-ranging differences in regulatory frameworks among major regions, including India, United States of America (USA) and Japan. The paper highlights crucial international efforts, such as those led by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) and the World Health Organization (WHO), which aim to create unified guidelines, standardize safety data formats and foster greater collaboration among countries. Furthermore, the article proposes practical strategies for building a cohesive and effective global pharmacovigilance ecosystem. These include adopting common technical standards, enhancing data-sharing mechanisms, investing in capacity building for lower-resource nations and encouraging multi-stakeholder engagement. Ultimately, achieving harmonization in pharmacovigilance is not merely a regulatory necessity - it is an ethical imperative to ensure that all patients, regardless of where they live, benefit from safe, effective and high-quality medicines.
Zitieren
APA
Manisha, M., Sheoran, D. R., Bala, S., Karunanidhi, K., Devi, S., & Pooja, P. (2026). Pharmacovigilance Harmonization: A Global Priority. International Journal of Drug Delivery Technology, 16(22s). https://doi.org/10.25258/ijddt.16.22s.14
Vancouver
Manisha M, Sheoran DR, Bala S, Karunanidhi K, Devi S, Pooja P. Pharmacovigilance Harmonization: A Global Priority. International Journal of Drug Delivery Technology. 2026;16(22s). doi:10.25258/ijddt.16.22s.14
BibTeX
@article{Manisha2026,
author = {Manisha, Manisha and Sheoran, Dr. Reena and Bala, Sanju and Karunanidhi, Karunanidhi and Devi, Sakshi and Pooja, Pooja},
title = {Pharmacovigilance Harmonization: A Global Priority},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {22s},
doi = {10.25258/ijddt.16.22s.14}
}
EUVIMED